Professor Dr Kai Simons
- Section Genetics/Molecular Biology and Cell Biology
- Location Dresden, Germany
- Election year 1999
Research
Research Priorities: Cell membrane, cellular polarity, intracellular transport of proteins and lipids, lipid rafts concept, interaction between viruses and cell membranes
Kai Simons is a Finnish doctor and biochemist who gained public acclaim for his research on cell membranes and viruses. His most important innovation was the development of the lipid raft concept.
To simplify the experimental challenge at the start of his long career, he introduced the envelope of Semliki Forest virus as the simplest bio membrane known as his experimental model. He shed light on how the virus gets into and out of its host cell, elucidating for the first time the life cycle of a membrane virus. He also developed an efficient protein subunit vaccine against Semliki Forest virus infection. Novavax used the same principles to design a protein vaccine against SARS-Cov-2 infections that worked as well as the RNA vaccines.
Next Simons tackled cell polarization to study how epithelial cell generate their asymmetric structure. He again used enveloped viruses as a tool to elucidate the epithelial membrane traffic system that generates the asymmetric cellular organisation. The highlight of these studies was the discovery of the lipid raft nanodomain concept, a general principle of cell membrane organisation that endows cholesterol-containing membranes with unique dynamic properties that provides the basis for many membrane functions. Several enveloped viruses such as influenza, HIV, measles and Ebola use lipid rafts to exit from its host sell to initial their infectious life cycle. Kai Simons built up the Cell Biology Programme at the European Molecular Biology Laboratory (EMBL) in Heidelberg and was the founding director of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden. Based on his lipid research, Simons also founded Lipotype GmbH in Dresden. Lipotype developed a unique mass spectrometric platform to analyse lipids in tissues and body fluids.
Kai Simons is now well-known for creating research environments where multidisciplinary research is facilitated by a cooperative atmosphere, supporting young researchers and generating innovation. He is a keen European through his activities not only at EMBL, but also in EMBO, ELSO and EU. Kai Simons summarized his life in research in his recent book “The Magic of the Collective” (2024) to inspire young researchers.
Kai Simons is a Finnish doctor and biochemist who gained public acclaim for his research on cell membranes and viruses. His most important innovation was the development of the lipid raft concept.
To simplify the experimental challenge at the start of his long career, he introduced the envelope of Semliki Forest virus as the simplest bio membrane known as his experimental model. He shed light on how the virus gets into and out of its host cell, elucidating for the first time the life cycle of a membrane virus. He also developed an efficient protein subunit vaccine against Semliki Forest virus infection. Novavax used the same principles to design a protein vaccine against SARS-Cov-2 infections that worked as well as the RNA vaccines.
Next Simons tackled cell polarization to study how epithelial cell generate their asymmetric structure. He again used enveloped viruses as a tool to elucidate the epithelial membrane traffic system that generates the asymmetric cellular organisation. The highlight of these studies was the discovery of the lipid raft nanodomain concept, a general principle of cell membrane organisation that endows cholesterol-containing membranes with unique dynamic properties that provides the basis for many membrane functions. Several enveloped viruses such as influenza, HIV, measles and Ebola use lipid rafts to exit from its host sell to initial their infectious life cycle. Kai Simons built up the Cell Biology Programme at the European Molecular Biology Laboratory (EMBL) in Heidelberg and was the founding director of the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden. Based on his lipid research, Simons also founded Lipotype GmbH in Dresden. Lipotype developed a unique mass spectrometric platform to analyse lipids in tissues and body fluids.
Kai Simons is now well-known for creating research environments where multidisciplinary research is facilitated by a cooperative atmosphere, supporting young researchers and generating innovation. He is a keen European through his activities not only at EMBL, but also in EMBO, ELSO and EU. Kai Simons summarized his life in research in his recent book “The Magic of the Collective” (2024) to inspire young researchers.
Career
- since 2012 Founder and CEO, Lipotype GmbH, Dresden, Germany
- since 2007 Director emeritus, Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), Dresden, Germany
- 1998-2006 Founding Director and Director, MPI-CBG, Dresden, Germany
- 1998-2014 Principal Investigator, Research Group, MPI-CBG, Dresden, Germany
- 1982-1998 Coordinator, Cell Biology Programme, The European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
- 1976-1979 Professor of Biochemistry, University of Helsinki, Helsinki, Finland
- 1975-2000 Principal Investigator, Research Group, EMBL, Heidelberg, Germany
- 1971-1972 Professor of Biochemistry, University of Helsinki, Helsinki, Finland
- 1967-1975 Research Associate, Finnish Medical Research Council, University of Helsinki, Helsinki, Finland
- 1965-1967 Postdoctoral Fellow, Rockefeller University, New York City, USA
- 1964 MD-PhD
- Degree in Medicine, University of Helsinki, Helsinki, Finland
Functions
- 2012-2018 Chairperson, Scientific Advisory Board, Gulbenkian Institute for Molecular Medicine (GIMM), Oeiras, Portugal
- 2012 Member, Scientific Advisory Board, Danish Stem Cell Center, Copenhagen, Denmark
- 2012 Member, Scientific Advisory Board, A.C. Camargo Hospital, São Paulo, Brazil
- 2011-2013 Member, Strategic Advisory Board, Sanofi, Boston, USA
- 2011 Member, Scientific Advisory Board, Biotechnology Center, Dresden University of Technology (TU), Dresden, Germany
- 2010-2012 Member, Board, biosaxony, Dresden, Germany
- 2007-2009 Member, Scientific Advisory Board, European Science Foundation (ESF)
- 2007-2008 Co-Director, Shanghai Institute for Advanced Studies, Chinese Academy of Sciences (CAS), China
- 2007-2018 Chairperson, Scientific Council, Institute for Molecular Medicine, Helsinki Institute of Life Science HiLIFE, University of Helsinki, Helsinki, Finland
- 2006-2010 Member and Chairperson, Review Panel “Starting Grants”, European Research Council (ERC)
- 2006 ‐ 2005 Member, Scientific Advisory Board, Institute of Biotechnology, University of Helsinki, Helsinki, Finland
- since 2006 Member, Scientific Advisory Board, Karolinska Institutet Sumitomo Pharmaceuticals Alzheimer Center (KASPAC), National Research School in Health Care Science (NFV), Karolinska Institutet, Stockholm, Sweden
- 2004-2009 Member, Council, European Molecular Biology Organization (EMBO)
- 2004-2006 Member, Executive Board, ESF
- 2003-2006 Member, Scientific Advisory Board, Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK
- 2003-2005 Member, Advisory Board, Janelia Research Campus, Howard Hughes Medical Institute, Chevy Chase, USA
- 2002-2010 Chairperson, BioDresden e.V., Dresden, Germany
- 2002-2004 Member, Scientific Advisory Board, Centre of Excellence, University of Oulu, Oulu, Finland
- since 2002 Member, Advisory Board, Institute & Graduate Schools of Biomembranes, Utrecht University, Utrecht, Netherlands
- since 2002 Member, Culture Board, City of Dresden, Germany
- since 2002 Chairperson, Scientific Advisory Board, Center for Genomic Regulation (CRG), Barcelona, Spain
- since 2001 Member, Scientific Advisory Board, GIMM, Oeiras, Portugal
- since 2001 Chairperson, Scientific Advisory Board, HUN-REN Biological Research Center (BRC), Szeged Centre of Excellence of the European Union, Szeged, Hungary
- since 2000 Member, Scientific Advisory Board, Biomedicum Helsinki, Helsinki, Finland
- 1999-2008 President, ELSO
- 1999-2000 Member, Council, American Society for Cell Biology, USA
- 1997-2006 Member, Advisory Board, Institute for Molecular Biotechnology, Jena, Germany
- 1997-1999 Member, Council, American Society for Cell Biology, USA
- 1994-2002 Member, Scientific Advisory Board, Biogen Inc., Cambridge, USA
- 1994-2000 Member, International Advisory Council, Basel Institute for Immunology, Basel, Switzerland
- 1994 Member, Scientific Advisory Board for the Establishment of a European Laboratory for Molecular Marine Biology (Michael Sars Centre, University of Bergen), Bergen, Norway
- 1992-2003 Member, Founding Committee, Max Delbrück Center for Molecular Medicine (MDC), Berlin, Germany
- 1992-1994 Member, “Life Sciences” Panel, R&D Programme “Human Capital and Mobility (HCM)”, 3rd Framework Programme for Research (FP), European Commission (EC)
- 1991-1997 Member and Chairperson, Scientific Advisory Board, Center for Molecular Biology, University of Heidelberg, Heidelberg, Germany
- 1991-1992 Member, Founding Committee, Leibniz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben, Germany
Honours and Memberships
- 2025 Cothenius Medal, German National Academy of Sciences Leopoldina
- 2021 Golden Badge of Honour, Dresden University of Technology, Dresden, Germany
- 2016 Robert Koch Medal in Gold, Robert Koch Foundation, Berlin, Germany
- 2012 Honorary Chairperson, biosaxony, Dresden, Germany
- 2007 Order of Merit, Free State of Saxony, Germany
- 2006 Honorary Member, Societas Biochemica, Helsinki, Finland
- 2005 Van Deenen Medal, Institute of Biomembranes, Utrecht University, Utrecht, the Netherlands
- 2004 Virchow Lecture and Medal, Julius Maximilians University of Würzburg (JMU), Würzburg, Germany
- 2003 Matti Äyräpää Prize, Finnish Medical Society Duodecim, Finland
- 2003 Honorary Doctorate, KU (Katholieke Universiteit) Leuven, Leuven, Belgium
- 2003 Albert Wander Prize, University of Bern, Bern, Switzerland
- 2003 2003 Nessim-Habif World Prize, University of Geneva, Geneva, Switzerland
- 2002 Felix Hoppe-Seyler Lecture
- 2001 Schleiden Medal, German National Academy of Sciences Leopoldina, Germany
- since 1999 Member, German National Academy of Sciences Leopoldina, Germany
- 1998 Honorary Doctorate, University of Oulu, Oulu, Finland
- 1998 Choh Hao Li Memorial Lecture, University of California, Berkeley, USA
- since 1997 Foreign Member, National Academy of Sciences (NAS), USA
- 1997 J.W. Runeberg Prize, Finnish Medical Society, Finland
- 1997 Adam Neville Lecture, University of Dundee, Dundee, UK
- 1996 Dunham Lecturer, Harvard University, Cambridge, USA
- since 1996 Foreign Member, American Academy of Arts and Sciences, USA
- 1993 Carl Zeiss Lecture, German Society for Cell Biology, Germany
- 1991 Anders Jahre’s Award for Medical Research, University of Oslo, Oslo, Norway
- 1990 Keith Porter Lecturer, American Society for Cell Biology, USA
- since 1989 Member, Academia Europaea
- since 1987 Member, Heidelberg Academy of Sciences, Heidelberg, Germany
- 1984 Honorary Doctorate, University of Heidelberg, Heidelberg, Germany
- since 1978 Member, Societas Scientiarum Fennica. Finnish Society of Sciences and Letters, Finland
- Honorary Doctorate: KU (Katholieke Universiteit) Leuven, Leuven, Belgium, University of Eastern Finland, Kuopio, Finland, and University of Geneva, Geneva, Switzerland